Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

How to Be Kind to Your Mind—featuring Russell Glass

The World Health Organization estimates that one billion people have a mental health condition, but 70% of them aren&#39;t getting care. So, what is the best way to address this supply-demand imbalance? How do we help someone with a clinical diagnosis manage their condition? And what can we do to support the mental health needs of people before they develop a serious issue? Russell Glass is CEO of <a href="https://www.headspacehealth.com/" target="_blank">Headspace Health</a>, the world’s most comprehensive and accessible mental health care platform. Russ leads the company in helping create a world where everyone is kind to their mind by way of mindfulness and meditation tools, behavioral health coaching, therapy and psychiatry services. On this episode of HLTH Matters, Russ joins host Dr. Guatam Gulati to explore the root causes of the mental health crisis in the US and explain the benefit of a virtual-first approach to care. Russ discusses how Headspace helps its members get the right level of care and what his team does to alert the appropriate authorities when a user has suicidal or homicidal intent. Listen in for Russ’ insight on the over-prescription of psychotropic drugs like Lexapro and learn how to prevent serious mental health issues with a simple mindfulness and meditation practice. Topics Covered <ul><li>Headspace Health’s mission to transform mental health care</li><li>The supply-demand imbalance that inspired Russ’ work in mental health</li><li>Why Russ takes a broad definition of mental health</li><li>How Headspace offers mindfulness/meditation, behavioral health coaching and therapy services</li><li>When virtual mental health interventions are appropriate and when in-person care works best</li><li>How fast we adopted virtual mental health solutions during COVID</li><li>The root causes of the mental health crisis in the US</li><li>How Headspace helps its members get the right level of care</li><li>How to prevent serious mental health issues with mindfulness and meditation</li><li>How Russ thinks about crime being attributed to the mental health crisis in the US </li><li>What Headspace does to alert the appropriate authorities when a member has suicidal or homicidal intent</li></ul>  Connect with Russell Glass<a href="https://www.headspacehealth.com/" target="_blank">Headspace Health</a>  Connect with Dr. Guatam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a>  Resources<a href="https://www.ginger.com/" target="_blank">Ginger</a><a href="https://health.gov/healthypeople/priority-areas/social-determinants-health" target="_blank">Social Determinants of Health</a><a href="https://www.hiv.uw.edu/page/mental-health-screening/gad-7" target="_blank">Generalized Anxiety Disorder Mental Health Assessment</a><a href="https://cssrs.columbia.edu/the-columbia-scale-c-ssrs/about-the-scale/" target="_blank">Columbia Suicide Severity Rating Scale</a><a href="https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2798510" target="_blank">‘Mindfulness-Based Stress Reduction vs. Escitalopram for the Treatment of Adults with Anxiety Disorders’ in JAMA Psychiatry</a>

S3 Ep15: How to Be Kind to Your Mind—featuring Russell Glass

Unlocking Seamless Healthcare Experiences with Digital Identity

From airports to the world of healthcare, digital identities have seamlessly transformed how we navigate and personalize our experiences. In this episode, Saul Marquez hosts Jason Sherwin, Senior Director of Business Development at Clear, and Ryan Howells, a Principal at Leavitt Partners and Program Manager at CARIN Alliance. The discussion delves into the significance of digital identity in healthcare. Jason explains how Clear&#39;s consumer-facing identity platform, known for its privacy and trust in the aviation industry, can empower safer and more convenient healthcare experiences. Ryan, representing the CARIN Alliance, highlights the importance of identity and patient data access, emphasizing their work in enabling consumers to control their health information. They both describe practical initiatives where consumers can access their health data easily, offering providers and payers the means to streamline processes and enhance patient experiences. Learn how digital identity solutions can revolutionize healthcare and make patient data more accessible and user-friendly. About Jason Sherwin:Jason Sherwin is the Senior Director of Business Development at Clear. He is a passionate strategic thinker who is driven to challenge long-held healthcare standards. Jason has 13 years of expertise in the health technology field, focusing on product planning and commercial growth. In his role at Clear, Jason works cross-functionally with executives and other leaders in marketing, operations, and IT to maximize outcomes. Jason completed his MBA at the Stern School of Business, which enabled him to apply the principles he learned to his real-world work. His expertise in designing successful strategies for managing organizational change and gauging success was further boosted by his specialization in Leadership &amp; Change Management. Jason also completed his Bachelor of Science at Skidmore College in 2009. About Ryan Howells:Ryan Howells is Principal at Leavitt Partners and Program Manager at CARIN Alliance. He focuses on healthcare policy and interoperability issues, working with key stakeholders, including the White House, Congress, HHS, and VHA. His role is instrumental in driving consumer access to healthcare data and enabling interoperability in the healthcare ecosystem. Ryan is also a Member of the Medicaid Information Technology Architecture (MITA) Governance Board at the Centers for Medicare &amp; Medicaid Services, intending to provide strategic direction and tactic oversight. Ryan has earned his Master of Arts in Health Services Administration at the University of Southern California. Things You’ll Learn:<ul><li>In healthcare, identity is critical. Getting the patient&#39;s identity wrong isn&#39;t an option.</li><li>Streamlining healthcare through digital identity can significantly reduce provider costs and improve patient matching.</li><li>The 21st Century Cures Act, Fire APIs, and identity-proof credentials are revolutionizing how consumers access their healthcare data.</li><li>Individuals can prove their identity, for example, when checking in for an appointment with their doctor, through a unique digital identity, similar to taking a selfie.</li><li>The goal is to place patients in control of their health information, providing a seamless experience.</li><li>Trust is a crucial aspect, making the digital identity a reliable solution for healthcare data.</li></ul> Resources:<ul><li>Connect with and follow Jason on <a href="https://www.linkedin.com/in/jasonsherwinhealth/" target="_blank">LinkedIn</a>.</li><li>Visit CLEAR on their <a href="https://www.clearme.com/" target="_blank">website</a> and follow them on <a href="https://www.linkedin.com/company/clear-by-alclear-llc/" target="_blank">LinkedIn</a>.</li><li>Connect with and follow Ryan on <a href="https://www.linkedin.com/in/ryanhowells/" target="_blank">LinkedIn</a>.</li><li>Learn more about Leavitt Partners on this <a href="https://leavittpartners.com/" target="_blank">website</a> and <a href="https://www.linkedin.com/company/leavitt-partners/" target="_blank">LinkedIn</a>.</li><li>Visit CARIN Alliance on their <a href="https://www.carinalliance.com/" target="_blank">website</a> and follow them on <a href="https://www.linkedin.com/company/carinalliance/" target="_blank">LinkedIn</a>.</li></ul>

S4 E8: Unlocking Seamless Healthcare Experiences with Digital Identity

Senior Director of Business Development

Principal

Patient-First, Personalized Cancer Care—featuring Robin Shah

Robin Shah is an oncology subject matter expert, building a career around startups in the cancer care space. So, he regularly receives phone calls from people whose friends, family members or colleagues have been diagnosed with cancer and don’t know what to do. And Robin wondered how he could help people in this way at scale. How could he support cancer patients who didn’t know someone like him? How could he help them navigate the healthcare system and get access to the right resource at the right time? Today, Robin serves as Founder and CEO of <a href="https://www.thymecare.com/" target="_blank">Thyme Care</a>, a value-based oncology management platform that provides personalized, clinically coordinated care to individuals with cancer. Thyme Care pairs human guidance with software and analytics to engage members with a cancer diagnosis, quickly connecting them to the right care and providing ongoing support through targeted, evidence-based interventions. On this episode of HLTH Matters, Robin joins host Dr. Jessica Shepherd to explain how Thyme Care’s tech-enabled team helps cancer patients find the help they need. Robin discusses his patient-first approach to solving problems in oncology, describing the psychosocial aspect of navigating cancer and why Thyme Care is the first company of its kind to focus on oncology. Listen in to understand how Thyme Care integrates directly with clinicians in a patient’s region and learn how Robin is improving the patient experience—while reducing the cost of care. Topics Covered <ul><li>What’s behind Robin’s passion for building companies in the oncology space</li><li>How Thyme Care helps cancer patients navigate the system and find the help they need</li><li>How Thyme Care gives patients someone to talk to (when physicians can’t)</li><li>Thyme Care’s tech-enabled team that provides the right resource at the right time</li><li>How Thyme Care offers clinical wraparound support today with an eye to eventually deliver care</li><li>How Robin’s team addresses the psychosocial aspect of navigating cancer</li><li>How Robin benefits from having family members who work in the oncology space</li><li>How Thyme Care integrates directly with providers in a patient’s region</li><li>How Thyme Care improves the patient experience while reducing the cost of care</li><li>Why Thyme Care is the first company of its kind to focus on oncology</li><li>The benefit of Robin’s patient-first approach to solving problems in oncology</li><li>How COVID inspired people to be more engaged in their healthcare journey</li></ul>  Connect with Robin Shah<a href="https://www.thymecare.com/" target="_blank">Thyme Care</a> Connect with Dr. Jessica Shepherd<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a> Resources<a href="https://flatiron.com/" target="_blank">Flatiron Health</a><a href="https://www.oneoncology.com/" target="_blank">OneOncology</a><a href="https://medium.com/authority-magazine/health-tech-robin-shah-on-how-thyme-cares-technology-can-make-an-important-impact-on-our-overall-7e562b7cba32" target="_blank">‘Robin Shah on How Thyme Care’s Technology Can Make an Important Impact on Overall Wellness’ in Authority Magazine</a>

S3 Ep19: Patient-First, Personalized Cancer Care—featuring Robin Shah

Founder & Chief Executive Officer

The Beat: Sanofi's Pattern Recognition in Vaccine Development

The vaccine business is highly competitive. But Sanofi stands out particularly well. In this episode, Deborah Glasser, Sanofi’s Head of Vaccines for North America, delves into Sanofi&#39;s extensive history in the vaccine business, focusing on areas such as influenza, neurology, and rare diseases. Deborah provides a glimpse into the groundbreaking RSV monoclonal antibody, Beyfortus, designed to protect infants from the leading cause of hospitalizations. She emphasizes the unique approach of using a monoclonal antibody for newborns, highlighting its potential to revolutionize RSV prevention. Deborah also touches on Sanofi&#39;s efforts in flu prevention, such as consumer education and the importance of immunization, especially for the vulnerable population aged 65 and older. She sheds light on Sanofi&#39;s innovative use of Artificial Intelligence (AI) in both drug discovery and commercial practices and shares Sanofi&#39;s interest in collaborating with startups, particularly those aligned with health system goals. Tune in and learn how Sanofi&#39;s dedication to science and technology shapes the landscape of vaccine development and public health. About Deborah Glasser:Deborah Glasser holds an MBA in Marketing and Finance from the University of Chicago Booth School of Business and a B.A. with honors from Tufts University. Deborah is currently the Head of Vaccines in North America at Sanofi. In this role, she spearheads a team committed to pursuing scientific breakthroughs, focusing on the development and enhancement of immunizations. Sanofi, a global pharmaceutical giant, places a strong emphasis on innovation, and Deborah plays a crucial role in driving the vision forward, expanding access to vaccines, and advancing public health initiatives throughout the U.S. and Canada. Drawing on a rich and varied professional background, Deborah brings more than a decade of experience to her current role. Her journey includes an illustrious 13-year tenure at Biogen, where she held diverse positions across its U.S., European, and global organizations. Notably, she played a key role in the successful launch of Tecfidera, an oral multiple sclerosis product that achieved remarkable success, generating $1.3 billion in U.S. sales within its first four full quarters on the market. Things You’ll Learn:<ul><li>The vaccine industry faces intense competition.</li><li>RSV stands as the primary reason for infant hospitalizations.</li><li>Approximately 70 out of every 100,000 individuals end up hospitalized due to the flu.</li><li>The flu poses a significant and serious risk, with an average of 36,000 deaths annually, potentially reaching 98,000 in severe seasons. These deaths are preventable.</li><li>It&#39;s crucial to recognize the seriousness of the flu and take preventive measures to avoid unnecessary fatalities.</li></ul> Resources:<ul><li>Connect with and follow Deborah Glasser on <a href="https://www.linkedin.com/in/deborah-glasser-b06643/" target="_blank">LinkedIn</a>.</li><li>Follow Sanofi on <a href="https://www.linkedin.com/company/sanofi/" target="_blank">LinkedIn</a> and visit their <a href="https://www.sanofi.com/en" target="_blank">website</a>.</li></ul>

S1 E6: The Beat: Sanofi's Pattern Recognition in Vaccine Development

Head of Vaccines, North America

Podcast

S3 Ep15: How to Be Kind to Your Mind—featuring Russell Glass

FEATURING